Deborah H. Telman - 12 Nov 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
12 Nov 2025
Transactions value $
-$3,084,602
Form type
4
Filing time
13 Nov 2025, 19:36:11 UTC
Previous filing
27 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Telman Deborah H EVP, Corporate Affairs & GC GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Deborah H. Telman 13 Nov 2025 0001860008

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $1.29M +17.2K +39.34% $75.12 60.9K 12 Nov 2025 Direct F1
transaction GILD Common Stock Sale -$2.13M -17.2K -28.23% $124.00 43.7K 12 Nov 2025 Direct F1
transaction GILD Common Stock Options Exercise $2.18M +36K +82.34% $60.75 79.6K 12 Nov 2025 Direct F1
transaction GILD Common Stock Sale -$4.4M -36K -45.16% $122.30 43.7K 12 Nov 2025 Direct F1, F2
transaction GILD Common Stock Options Exercise $30.4K +500 +1.14% $60.75 44.2K 12 Nov 2025 Direct F1
transaction GILD Common Stock Sale -$61.5K -500 -1.13% $122.90 43.7K 12 Nov 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -17.2K -31.25% $0.00 37.8K 12 Nov 2025 Common Stock 17.2K $75.12 Direct F1, F4
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -36K -73.97% $0.00 12.7K 12 Nov 2025 Common Stock 36K $60.75 Direct F1, F4
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -500 -3.95% $0.00 12.2K 12 Nov 2025 Common Stock 500 $60.75 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
F2 Sales prices for the transactions reported here range from $121.87 to $122.83. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F3 Sales prices for the transactions reported here range from $122.88 to $122.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4 The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.